skip to Main Content

Roche announce changes to compassion access program in light of Covid-19

  • 17 April 2020

We know across the world that people have been struggling to receive their Spinraza treatment because of the coronavirus causing significant hospital capacity and safety issues. Roche today have announced that they are relaxing their compassion access program eligibility criteria to help those who have been affected by this. Statement below:

Read More

Advice from clinicians on COVID -19

  • 1 April 2020

Many people reached out through their PAG to contact clinicians, and as a result MDUK has compiled the following regarding muscle wasting conditions. please see below for information written and compiled by MDUK which we would like to share.

Read More
Back To Top